Home
>>
Products
>>
Antibodies
>>
Recombinant Antibodies
>
Anti-Human CD22 Recombinant Antibody(Epratuzumab)

Anti-Human CD22 Recombinant Antibody(Epratuzumab)

Product Number

YR1021

Alias

科研级 Epratuzumab ( 依帕珠单抗 ), Anti-CD22 Recombinant Antibody, Research Grade Epratuzumab

Specifications
  • 1mg
  • 5mg
Product Description
Alias科研级 Epratuzumab ( 依帕珠单抗 ), Anti-CD22 Recombinant Antibody, Research Grade Epratuzumab
Catalog NumberYR1021
Molecular NameEpratuzumab
HostMouse
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeIgG1
FormulationPBS, pH7.5
BackgroundEpratuzumab (planned trade name LymphoCide) is a humanized monoclonal antibody. Potential uses may be found in oncology and in treatment of inflammatory autoimmune disorders, such as systemic lupus erythematosus (SLE).
CAS Number205923-57-5
ApplicationIF, IP, Neut, FuncS, ELISA, FCM, ICC, Activ, WB
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
TargetCD22[Homo sapiens]

Login

Don’t have an account?Sign Up Now

Register

Already have an account?Log In Now

Inquire Now